| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.2B | $1.0B | $1.2B | $0.3B | $0.3B | $0.3B | $0.3B |
| Cost of Revenue | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B | $0.6B | $0.6B | $0.6B |
| Gross Profit | $0.5B | $0.1B | $0.6B | $0.7B | $0.2B | $0.2B | $0.2B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| Operating Income | $-0.2B | $-0.0B | $-0.3B | $0.2B | $0.0B | $0.1B | $0.1B | $0.0B |
| Net Income | $-0.3B | $-0.1B | $-0.3B | $0.1B | $0.0B | $0.0B | $0.2B | $0.2B |
| EPS (Basic) | $-4.34 | $-1.11 | $-3.58 | $0.96 | $0.18 | $0.44 | $0.65 | $0.97 |
| EPS (Diluted) | $-4.34 | $-1.11 | $-3.58 | $0.95 | $0.18 | $0.42 | $0.63 | $0.91 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.6B | $1.0B | $1.0B | $1.4B | $1.5B | $1.5B | $1.4B | $1.2B |
| Current Assets | $0.1B | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | $0.2B |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $1.7B | $1.7B | $1.7B | $1.9B | $2.0B | $2.2B | $2.2B | $2.3B |
| Current Liabilities | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B | $0.3B | $0.3B |
| Stockholders' Equity | $-1.1B | $-0.8B | $-0.7B | $-0.5B | $-0.5B | $-0.7B | $-0.8B | $-1.0B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.0B | $0.1B | $0.2B | $0.1B | $0.2B | $0.3B | — |
| Investing Cash Flow | $-0.0B | $-0.1B | $-0.0B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.0B | $-0.0B | $-0.1B | $-0.1B | $-0.2B | $-0.1B | — |